Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Bullboard Posts
Comment by beercanon Jun 10, 2013 6:37am
136 Views
Post# 21505705

RE: not good!! no answers????????????

RE: not good!! no answers????????????

Reading  this it looks like we are the ONLY ones in contention here..It looks like a lock and done deal real soon.

6. Efforts to Obtain Competition: None. No effort will be made to solicit offers from others,

as there is only one source capable of performing the required services. The initial contract

award was competed in 2010, and of the three offerors only one company, MedMira, was

identified as capable of performing the work. Recent market research confirms that there has

been no change in this situation.

7. Actions to Increase Competition: None. No effort will be made to increase competition as

there is only one source capable of performing the required services.

8. Market Research: Market research is being conducted on an ongoing basis via internet and

peer-reviewed literature searches by the RT2D2 product manager. Manufacturers of rapid

human immunodeficiency virus (HIV) and hepatitis C (HCV) tests FDA-approved for use as

diagnostic aids have been identified; however, there are no manufacturers of FDA-approved

rapid hepatitis B (HBV) tests, and none of the currently available tests are FDA-approved for

use as blood donor screens in urgent situations.

Bullboard Posts